Loading...
Market
Will the MVA-BN vaccine receive EMA approval by the end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official announcements from the European Medicines Agency (EMA)
Story
WHO Prequalifies Bavarian Nordic's MVA-BN Vaccine as First Mpox Shot on Friday, Approved in Mexico
Sep 13, 2024, 09:45 AM
The World Health Organization (WHO) has prequalified the MVA-BN vaccine, developed by Bavarian Nordic, as the first vaccine against mpox. This approval, announced on Friday, marks a significant step towards expanding access and reducing transmission in high-risk communities. Additionally, the vaccine has been approved for emergency use in Mexico by Cofepris.
View original story
Similar markets
Approved without conditions • 25%
Approved with conditions • 25%
Not approved • 25%
Decision delayed • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Approved by Q3 2024 • 25%
Approved by Q4 2024 • 25%
Approved by Q1 2025 • 25%
Not approved by Q1 2025 • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
